Welcome to our dedicated page for Varex Imaging news (Ticker: VREX), a resource for investors and traders seeking the latest updates and insights on Varex Imaging stock.
Varex Imaging Corporation (NASDAQ: VREX) is a designer and manufacturer of X-ray imaging components and systems used in medical, industrial, and security applications. The VREX news page on Stock Titan aggregates company announcements, earnings releases, conference presentations, and product-related updates so readers can follow how the business is evolving over time.
Recent news for Varex has focused on quarterly and annual financial results, including detailed segment reporting for its Medical and Industrial businesses, as well as reconciliations between GAAP and non-GAAP financial measures. Earnings releases typically discuss revenue trends in medical X-ray components, demand in industrial imaging, and developments affecting specific markets such as China. Management commentary often highlights factors such as segment performance, margins, cash flow from operations, and capital structure items like convertible notes and senior secured notes.
In addition to financial results, Varex issues news about orders and deployments of its high-energy non-intrusive cargo and vehicle inspection systems. These announcements describe international customers placing systems at strategic sea and land ports and reference the company’s reputation in high-energy Linear Accelerator based imaging. The news flow also includes updates on investor conference appearances, where management presents at events hosted by firms such as CJS Securities, Sidoti, and Jefferies.
Visitors to the VREX news page can use this stream of press releases and updates to monitor trends in medical imaging components, industrial and security imaging systems, cargo inspection orders, and corporate developments. Bookmarking the page allows investors and observers to review new announcements alongside prior releases for context on Varex Imaging Corporation’s ongoing disclosures.
Varex Imaging Corporation (Nasdaq: VREX) reported record Q4 FY22 revenues of $231 million, with a GAAP gross margin of 32% and a non-GAAP operating margin of 13%. For FY22, total revenues reached $859 million, marking a 10% operating margin. Q4 earnings were $0.32 GAAP and $0.42 non-GAAP per diluted share. Despite supply chain challenges, the company saw an 8% sequential revenue increase driven by growth in Medical and Industrial segments. For Q1 FY23, Varex expects revenues between $195 million and $215 million.
Varex Imaging Corporation (Nasdaq: VREX) announced it will release unaudited financial results for Q4 and fiscal year 2022 after market close on November 15, 2022. A conference call will follow at 3:00 pm MT, available via webcast on the company's website. Varex specializes in X-ray imaging components, including tubes and digital detectors, utilized in medical and security sectors. With over 2,100 employees globally, Varex continues its 70+ year history of innovation in the imaging industry.
Varex Imaging Corporation (Nasdaq: VREX) has appointed Kathleen L. Bardwell to its Board of Directors, effective July 29, 2022. Bardwell, with over 35 years of experience in regulatory affairs and compliance, previously served as Senior Vice President at STERIS Corporation. Her extensive background in quality and regulatory matters is expected to enhance Varex's governance. The board has increased its size from seven to eight members. Bardwell has also held various key roles in other financial institutions and is affiliated with professional organizations such as NACD and AICPA.
Varex Imaging Corporation (Nasdaq: VREX) reported its unaudited financial results for Q3 FY22, with revenues of $214 million, reflecting a 2% increase year-over-year. The GAAP net earnings were $0.20 per diluted share, and non-GAAP net earnings were $0.37 per diluted share. While revenues remained flat sequentially, the Industrial segment saw a 7% increase. However, cash flow from operations was a use of $3 million, reflecting ongoing investments in inventory. Looking ahead, Q4 FY22 guidance suggests revenues between $210 million and $240 million.
Varex Imaging Corporation (Nasdaq: VREX) will report its unaudited financial results for the third quarter of fiscal year 2022 on August 2, 2022, after market close. A conference call is scheduled for 3:00 PM Mountain Time on the same day, accessible via webcast and phone. Varex specializes in X-ray imaging components and employs approximately 2,100 individuals globally. The company continues to innovate in medical and industrial imaging sectors, showcasing over 70 years of expertise in designing critical X-ray systems.
Varex Imaging Corporation (Nasdaq: VREX) reported its unaudited financial results for Q2 FY22, achieving revenues of $215 million, an 8% sequential increase. The GAAP gross margin was 33%, while the non-GAAP gross margin stood at 34%. Non-GAAP net earnings per diluted share improved to $0.37 from $0.25 in the prior quarter. Despite ongoing supply chain constraints, strong demand persists. However, operational cash flow decreased by $8 million, and cash and cash equivalents fell to $115 million following a $27 million redemption of Senior Secured Notes.
Varex Imaging Corporation (Nasdaq: VREX) will report its unaudited financial results for Q2 FY2022 on May 3, 2022, after market close. The earnings release will be followed by a conference call at 3:00 PM MT, accessible via their website or through call-in options. A replay will be available from May 3rd to May 17th. Varex specializes in X-ray imaging components and has over 70 years of experience in the industry, providing critical systems for medical, industrial, and security applications.
Varex Imaging Corporation (Nasdaq: VREX) will present at Oppenheimer's 32nd Annual Healthcare Conference on March 15, 2022, at 2:40 pm ET. The presentation will be available via webcast, accessible through Varex's website. CFO Sam Maheshwari will discuss the company’s business overview during the event.
Varex specializes in X-ray imaging components for medical and industrial applications, boasting over 70 years of innovation. The company is headquartered in Salt Lake City, employing around 2,100 people globally.
Varex Imaging Corporation (Nasdaq: VREX) announced a partial redemption of $27 million in its 7.875% senior secured notes due 2027, totaling 10% of the outstanding principal. The redemption price is set at 103% of the principal plus accrued interest, reducing the remaining principal to $243 million. This strategic move is expected to lower ongoing cash interest expenses by $2.1 million, as stated by CFO Sam Maheshwari. Varex continues to focus on cash generation to manage its debt effectively.
Varex Imaging Corporation (Nasdaq: VREX) reported unaudited financial results for 1QFY22, showing revenues of $199 million, down 12% sequentially but up 12% year-over-year. The GAAP gross margin was 33%, with non-GAAP operating margin at 11%. However, supply chain constraints impacted revenue fulfillment, leading to lower-than-expected results. Non-GAAP EPS stood at $0.25, while cash and cash equivalents rose to $158 million. For 2QFY22, revenue guidance is projected between $190 million and $220 million.
FAQ
What is the current stock price of Varex Imaging (VREX)?
What is the market cap of Varex Imaging (VREX)?
